The Effect of Sitagliptin on Brown Adipose Tissue and Whole-body Metabolism in Overweight Pre-diabetic Men
Phase of Trial: Phase IV
Latest Information Update: 11 Nov 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Overweight
- Focus Therapeutic Use
- Acronyms SitaBAT
- 07 Jun 2017 Biomarkers information updated
- 11 Nov 2016 Status changed from recruiting to completed.
- 24 Mar 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov.